The keyword also touches upon a critical medical condition: (Nonalcoholic Steatohepatitis). Understanding NASH in Modern Medicine
), which is a key therapeutic candidate in the Nonalcoholic Steatohepatitis (NASH) pipeline. NASH-246 from there-once again just ask......
NASH is notoriously heterogeneous. A drug may reduce steatosis but not fibrosis, or vice versa. Fixed-duration trials miss late responders. Adaptive designs with re-consent are rare but valuable because: The keyword also touches upon a critical medical